Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS) First published 21/02/2025 Last updated 06/05/2025 EU PAS number:EUPAS1000000441 Study Ongoing